World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
134
Citations
71454
World Ranking
2140
National Ranking
227

Overview

Philip N. Hawkins is affiliated with University College London in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to several subfields including Molecular Biology, Nephrology, Genetics, Pulmonary and Respiratory Medicine, and Epidemiology.

The main topics of their work cover Amyloidosis diagnosis, treatment, and outcomes, Parathyroid disorders and treatments, Medical imaging and pathology studies, Neuroendocrine tumor research advances, Peptidase inhibition and analysis, Eosinophilic disorders and syndromes, and Dermatological and skeletal disorders.

Their recent research publications include:

  • Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis, 2020, Journal of the American College of Cardiology
  • Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy, 2020, Journal of Neurology
  • Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation, 2020, European Heart Journal
  • Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years, 2022, Circulation
  • Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression, 2020, JACC. Cardiovascular imaging

Frequent co-authors collaborating with Philip N. Hawkins include:

  • Julian D. Gillmore
  • Helen J. Lachmann
  • Marianna Fontana
  • Ana Martinez-Naharro
  • Carol Whelan

Philip N. Hawkins has published frequently in journals such as:

  • European Heart Journal
  • JACC. Cardiovascular imaging
  • Circulation
  • European Journal of Heart Failure
  • Blood

Best Publications

  • Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams;Alejandra Gonzalez-Duarte;William D. O'Riordan;Chih Chao Yang

  • NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder

    Laetitia Agostini;Fabio Martinon;Kimberly Burns;Michael F. McDermott

  • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand

  • Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

    Julian D. Gillmore;Mathew S. Maurer;Rodney H. Falk;Giampaolo Merlini

  • Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

    David R. Booth;Margaret Sunde;Vittorio Bellotti;Vittorio Bellotti;Carol V. Robinson

  • Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

    Alicia Maria Maceira;Jayshree Joshi;Sanjay Kumar Prasad;James Charles Moon

  • Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition

    Raphaela Goldbach-Mansky;Natalie J Dailey;Scott W Canna;Ana Gelabert

  • Natural history and outcome in systemic AA amyloidosis.

    Helen J Lachmann;Hugh J B Goodman;Janet A Gilbertson;J Ruth Gallimore

  • Safety and efficacy of RNAi therapy for transthyretin amyloidosis

    Teresa Coelho;David Adams;Ana Silva;Pierre Lozeron

  • Use of canakinumab in the cryopyrin-associated periodic syndrome.

    Helen J Lachmann;Isabelle Kone-Paut;Jasmin B Kuemmerle-Deschner;Kieron S Leslie

  • New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

    Giovanni Palladini;Angela Dispenzieri;Morie A. Gertz;Shaji Kumar

  • Targeting C-reactive protein for the treatment of cardiovascular disease

    Mark B Pepys;Gideon M Hirschfield;Glenys A Tennent;J Ruth Gallimore

  • Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

    D M Vigushin;M B Pepys;P N Hawkins

  • Human lysozyme gene mutations cause hereditary systemic amyloidosis

    M. B. Pepys;P. N. Hawkins;D. R. Booth;D. M. Vigushin

  • Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

    Helen J Lachmann;David R Booth;Susanne E Booth;Alison Bybee

  • Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

    Theodoros D. Karamitsos;Stefan K. Piechnik;Sanjay M. Banypersad;Marianna Fontana

  • Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.

    Julian D Gillmore;Laurence B Lovat;Malcolm R Persey;Mark B Pepys

  • Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra

    Philip N. Hawkins;Helen J. Lachmann;Ebun Aganna;Michael F. McDermott

  • Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

    M. B. Pepys;J. Herbert;W. L. Hutchinson;G. A. Tennent

  • Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis

    G Holmgren;L Steen;O Suhr;B.-G Ericzon

Frequent Co-Authors

Mark B. Pepys
Mark B. Pepys University College London
Julian D. Gillmore
Julian D. Gillmore University College London
Helen J. Lachmann
Helen J. Lachmann University College London
James C. Moon
James C. Moon University College London
Michael F. McDermott
Michael F. McDermott University of Leeds
David R. Booth
David R. Booth University of Sydney
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Graham A. Hitman
Graham A. Hitman Queen Mary University of London
Vittorio Bellotti
Vittorio Bellotti University College London
J. Justin Hsuan
J. Justin Hsuan University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine? Numerous online degrees in nutrition offer foundational knowledge for healthcare roles, focusing on health, wellness, and disease prevention. This path can be ideal for those interested in dietetics or public health.

For those seeking leadership and administrative roles, accredited mha programs prepare graduates to manage hospitals, clinics, and other health organizations. These programs are recognized for meeting industry standards and typically offer flexible online study options.

Registered nurses looking to advance can consider online rn-bsn programs without clinicals, allowing them to earn their bachelor’s degree through fully online coursework. This is a convenient pathway for working professionals aiming to expand their qualifications.

If you're ready for doctoral study, accelerated dnp programs help experienced nurses achieve the highest clinical degree in a shorter time. These programs emphasize advanced practice and leadership, meeting the growing demand for highly skilled healthcare providers.

Best Scientists Citing Philip N. Hawkins

Trending Scientists

Recently Published Articles